Skip to main content

Table 1 Baseline demographics, clinical characteristics and laboratory results in successful and persistent subgroups of SHPT patients

From: Predictive value of characteristics of resected parathyroid glands for persistent secondary hyperparathyroidism during parathyroidectomy

Clinical characteristics

Successful PTX (n = 165)

Persistent SHPT (n = 62)

Demographics

Age (y)

46.74 ± 10.33

45.39 ± 10.69

Gender (male/female)

100/65

35/27

Dialysis mode, n (%)

Hemodialysis

153 (93%)

58 (94%)

Peritoneal dialysis

12 (7%)

4 (6%)

Dialysis vintage(months)

92.27 ± 41.17

95.56 ± 47.10

Laboratory values

Hemoglobin (g/L)

101.70 ± 20.34

106.10 ± 19.12

Creatinine (umol/L)

915.70 ± 262.49

945.38 ± 263.99

Urea (mmol/L)

23.61 ± 7.12

24.87 ± 8.25

Albumin (g/L)

38.34 ± 3.63

38.42 ± 3.73

cCa (mmol/L)

2.62 ± 0.26

2.59 ± 0.21

Phosphorus (mmol/L)

2.18 ± 0.57

2.18 ± 0.52

ALP (U/L)

311.8 (161.0, 768.7)

353.9 (149.6, 671.9)

ln ALP

5.84 ± 0.97

5.80 ± 0.92

iPTH (pg/ml)

1971.8 (1508.3, 2670.2)

2237.7 (1551.3, 3092.5)

ln iPTH

7.53 ± 0.48

7.60 ± 0.49

  1. None of the differences between two groups is significant (p > 0.05)
  2. Data are presented as mean ± SD, numbers, percentages and quartile, as appropriate
  3. SHPT, secondary hyperparathyroidism; cCa, corrected calcium; ALP, alkaline phosphatase; iPTH, intact parathyroid hormone; ln, the natural logarithm